SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-011101
Filing Date
2017-05-15
Accepted
2017-05-15 17:35:30
Documents
51
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q thld-10q_20170331.htm 10-Q 1457718
2 EX-10.1 thld-ex101_202.htm EX-10.1 452942
3 EX-31.1 thld-ex311_9.htm EX-31.1 15727
4 EX-31.2 thld-ex312_7.htm EX-31.2 15766
5 EX-32.1 thld-ex321_8.htm EX-32.1 6182
6 EX-32.2 thld-ex322_11.htm EX-32.2 6280
  Complete submission text file 0001564590-17-011101.txt   5360609

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT thld-20170331.xml EX-101.INS 1112574
8 XBRL TAXONOMY EXTENSION SCHEMA thld-20170331.xsd EX-101.SCH 29108
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thld-20170331_cal.xml EX-101.CAL 30410
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thld-20170331_def.xml EX-101.DEF 93408
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE thld-20170331_lab.xml EX-101.LAB 247872
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thld-20170331_pre.xml EX-101.PRE 194484
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 17846180
SIC: 2834 Pharmaceutical Preparations